PR002525 (Project)

Description:Interstitial lung diseases (ILDs) include a variety of inflammatory and fibrotic pulmonary conditions. This study employs high-resolution metabolomics (HRM) to explore plasma metabolites and pathways across ILD phenotypes, including non-fibrotic ILD, idiopathic pulmonary fibrosis (IPF), and non-IPF fibrotic ILD.
Results found

Linked to

 

Label

Description

 

Project

Metabolomics

Subject

A subject from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project

Biosample

A biosample from Metabolomics produced as part of the PR002525 project


  • Subject

    A subject from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002525 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.